Spleen stiffness test for liver disease
Part of Digestive system clinical trials.
This study looks at whether measuring the stiffness of the spleen with a special ultrasound-like test (Fibroscan) can help doctors better understand and monitor PBC, a chronic liver disease. The goal is to see if this simple test can give useful information about how the disease is progressing.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years old or older
- You have been diagnosed with primary biliary cholangitis (PBC)
- You are currently being treated with ursodeoxycholic acid or bezafibrate
- You are seen as an outpatient at UZ Brussels
- You can safely have a Fibroscan (no fluid in the belly or severe heart failure)
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests a new ultrasound method that measures spleen stiffness to help diagnose enlarged veins in the esophagus (esophageal varices) in people with chronic liver disease. It aims to find a less invasive way to detect these veins, which can cause serious bleeding.
This study measures how malnutrition affects liver and spleen stiffness (tissue hardness) in children using a non-invasive ultrasound test called elastography. It compares these measurements between malnourished children and healthy children to understand potential organ changes.
This trial uses a non-invasive ultrasound test to measure spleen stiffness, which may help find problems with blood pressure in the liver and identify enlarged veins that can bleed. It could help avoid more invasive tests.
This study tests a new way to measure liver scarring using a non-invasive ultrasound of the spleen (spleen stiffness measurement). It's for people with fatty liver disease (MASLD) who have advanced fibrosis (scarring) to see if this method can accurately detect the severity of liver damage.
This study tests a new way to measure spleen stiffness in veterans with metabolic-dysfunction fatty liver disease. It may help doctors better understand and monitor this condition without invasive procedures.
This study compares two non-invasive ultrasound methods (EUS-SWQ and FibroScan) with liver biopsy to see how well they detect liver scarring in patients with chronic liver disease. The goal is to improve how doctors diagnose and monitor liver damage from conditions like hepatitis B and fatty liver disease.
Hear when a new Primary Biliary Cholangitis trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.